Evidence map›Paper›PMID 38559078›Full record

ArticlebioRxiv : the preprint server for biology2024

Integrated

Praveen Agrawal, Shuhui Chen, Ana de Pablos, Faezeh Jame-Chenarboo, Eleazar Miera Saenz de Vega, Farbod Darvishian, Iman Osman, Amaia Lujambio, Lara K Mahal, Eva Hernando

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Praveen AgrawalDepartment of Pathology, NYU Grossman School of Medicine, New York.
Shuhui ChenDepartment of Chemistry, New York University.
Ana de PablosDepartment of Pathology, NYU Grossman School of Medicine, New York.
Faezeh Jame-ChenarbooDepartment of Chemistry, University of Alberta, Edmonton, Canada.
Eleazar Miera Saenz de VegaDepartment of Dermatology, NYU Grossman School of Medicine, New York.
Farbod DarvishianDepartment of Pathology, NYU Grossman School of Medicine, New York.
Iman OsmanInterdisciplinary Melanoma Cooperative Group, Perlmutter Cancer Center, NYU Langone Health.
Amaia LujambioIcahn School of Medicine at Mount Sinai, New York.
Lara K MahalDepartment of Chemistry, New York University.
Eva HernandoDepartment of Pathology, NYU Grossman School of Medicine, New York.
Eastern Cooperative Oncology Group · USNew York University · USUniversity of Alberta · CAAlbert Einstein College of Medicine · USIcahn School of Medicine at Mount Sinai · US

Funding

Project 3: The Evolving Role of Regional Lymph Nodes in Melanoma ProgressionU54CA263001 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Eva Hernando, Iman Osman · 2022 to 2026
$11.6M
Post-translational control of cancer cell stress response and metastasisR01CA202027 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI AIFANTIS, IANNIS, HERNANDO, EVA · 2016 to 2020
$2.3M
NCI NIH HHS R01 CA202027NCI NIH HHS U54 CA263001
6 · The paper itself

Abstract

Glycosylation is a hallmark of cancer biology, and altered glycosylation influences multiple facets of melanoma growth and progression. To identify glycosyltransferases, glycans, and glycoproteins essential for melanoma maintenance, we conducted an

Indexed as

cell growthglycosyltransferaseMelanomaST3GAL1ST3GAL2α-2,3 sialylation

Identifiers

PMID38559078
PMCPMC10979837
OpenAlexW4392886288

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.